Find verified Ixazomib Citrate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Ixazomib Citrate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Ixazomib Citrate API.
Alternate Names: NINLARO, Ixazomib citrate (Ester)
CAS No: 1239908-20-3
Molecular Formula: C20H23BCl2N2O9
Mol. Weight: 517.1 g/mol
IUPAC Name: 2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid
API Description: Ixazomib Citrate is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for multiple myeloma and has 14 investigational indications.
